Trinity Biotech to Announce Q2 2024 Financial Results
Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company specializing in diabetes management solutions and human diagnostics, has announced it will release its Q2 2024 financial results on Wednesday, August 14, 2024. The company will host a conference call at 8:30 AM ET on the same day to discuss the results.
Investors and interested parties can access the call through various methods:
- US Toll-Free: 1-877-407-0784
- International: 1-201-689-8560
- Conference ID: 13748426
- Webcast link available
- Call me™ feature: https://callme.viavid.com/viavid/?callme=true&passcode=13743417&h=true&info=company-email&r=true&B=6
Trinity Biotech plc (Nasdaq: TRIB), un'azienda biotecnologica attiva nella fase commerciale specializzata in soluzioni per la gestione del diabete e diagnostica umana, ha annunciato che rilascerà i suoi risultati finanziari del Q2 2024 mercoledì 14 agosto 2024. L'azienda terrà una teleconferenza alle 8:30 AM ET dello stesso giorno per discutere i risultati.
Gli investitori e le parti interessate possono accedere alla chiamata attraverso vari metodi:
- Numero verde USA: 1-877-407-0784
- Internazionale: 1-201-689-8560
- ID conferenza: 13748426
- Link per la webconferenza disponibile
- Funzione Call me™: https://callme.viavid.com/viavid/?callme=true&passcode=13743417&h=true&info=company-email&r=true&B=6
Trinity Biotech plc (Nasdaq: TRIB), una empresa de biotecnología en etapa comercial especializada en soluciones para la gestión de la diabetes y diagnósticos humanos, ha anunciado que publicará sus resultados financieros del Q2 2024 el miércoles 14 de agosto de 2024. La empresa llevará a cabo una llamada de conferencia a las 8:30 AM ET el mismo día para discutir los resultados.
Los inversores y partes interesadas pueden acceder a la llamada a través de varios métodos:
- Número gratuito de EE. UU.: 1-877-407-0784
- Internacional: 1-201-689-8560
- ID de conferencia: 13748426
- Link de la webconferencia disponible
- Características de Call me™: https://callme.viavid.com/viavid/?callme=true&passcode=13743417&h=true&info=company-email&r=true&B=6
Trinity Biotech plc (Nasdaq: TRIB)는 당뇨병 관리 솔루션 및 인체 진단에 특화된 상업 단계의 생명공학 회사로, 2024년 2분기 재무 결과를 2024년 8월 14일 수요일에 발표한다고 발표했습니다. 회사는 같은 날 오전 8시 30분 ET에 결과에 대해 논의하기 위한 컨퍼런스 콜을 진행할 예정입니다.
투자자 및 관련자는 다양한 방법으로 콜에 액세스할 수 있습니다:
- 미국 무료 전화: 1-877-407-0784
- 국제 전화: 1-201-689-8560
- 컨퍼런스 ID: 13748426
- 웹캐스트 링크 사용 가능
- Call me™ 기능: https://callme.viavid.com/viavid/?callme=true&passcode=13743417&h=true&info=company-email&r=true&B=6
Trinity Biotech plc (Nasdaq: TRIB), une entreprise de biotechnologie en phase commerciale spécialisée dans les solutions de gestion du diabète et le diagnostic humain, a annoncé qu'elle publiera ses résultats financiers du T2 2024 le mercredi 14 août 2024. L'entreprise organisera une conférence téléphonique le même jour à 8h30 ET pour discuter des résultats.
Les investisseurs et parties intéressées peuvent accéder à l'appel par divers moyens :
- Numéro sans frais aux États-Unis : 1-877-407-0784
- International : 1-201-689-8560
- ID de conférence : 13748426
- Lien de web diffusion disponible
- Fonction Call me™ : https://callme.viavid.com/viavid/?callme=true&passcode=13743417&h=true&info=company-email&r=true&B=6
Trinity Biotech plc (Nasdaq: TRIB), ein biotechnologisches Unternehmen in der kommerziellen Phase, das sich auf Lösungen zur Diabetesbewältigung und menschliche Diagnostik spezialisiert hat, hat angekündigt, dass es am Mittwoch, dem 14. August 2024, seine Finanzergebnisse für das 2. Quartal 2024 bekannt geben wird. Das Unternehmen wird am selben Tag um 8:30 AM ET eine Telefonkonferenz abhalten, um die Ergebnisse zu erörtern.
Investoren und interessierte Parteien können auf die Konferenz auf verschiedene Weise zugreifen:
- US-Hotline: 1-877-407-0784
- International: 1-201-689-8560
- Konferenz-ID: 13748426
- Webcast-Link verfügbar
- Call me™-Funktion: https://callme.viavid.com/viavid/?callme=true&passcode=13743417&h=true&info=company-email&r=true&B=6
- Trinity Biotech is maintaining transparency by hosting a quarterly earnings call
- The company offers multiple ways for investors to access the financial results and participate in the call
- None.
Conference Call Scheduled for Wednesday, August 14, 2024 at 8:30 AM ET
DUBLIN, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, will report financial results for the second quarter 2024 on Wednesday, August 14, 2024 at 8:30 AM ET.
Conference Call Dial-In & Webcast Information
| Date: | Wednesday, August 14, 2024 |
| Time: | 8:30 AM ET |
| United States: | 1-877-407-0784 |
| International: | 1- 201-689-8560 |
| Conference ID: | 13748426 |
| Webcast: | webcast link |
| Call me™: | https://callme.viavid.com/viavid/?callme=true&passcode=13743417&h=true&info=company-email&r=true&B=6 |
About Trinity Biotech
Trinity Biotech is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has recently entered the wearable biosensor industry, with the acquisition of the biosensor assets of Waveform Technologies Inc. and intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. The products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide. For further information, please see the Company's website: www.trinitybiotech.com
| Contact: | Trinity Biotech plc | LifeSci Partners, LLC |
| John Gillard | Eric Ribner | |
| (353)-1-2769800 | (1)-646-751-4363 | |
| E-mail: john.gillard@trinitybiotech.com | E-mail: investorrelations@trinitybiotech.com |
FAQ
When will Trinity Biotech (TRIB) release its Q2 2024 financial results?
What time is Trinity Biotech's (TRIB) Q2 2024 earnings call scheduled for?
How can investors join Trinity Biotech's (TRIB) Q2 2024 earnings call?
What is Trinity Biotech's (TRIB) main business focus?
